Mechanisms of action of thymoglobulin

被引:36
作者
Mueller, Thomas F. [1 ]
机构
[1] Univ Alberta Hosp, Edmonton, AB T8G 2B7, Canada
关键词
anti-thymocyte globulin; depletion; adhesion molecules; apoptosis; regulation; ischemia-reperfusion;
D O I
10.1097/01.tp.0000295420.49063.b1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Thymoglobulin (Genzyme Transplant, Cambridge, MA) is a polyclonal rabbit anti-thymocyte globulin that consists of a mixture of different antibody specificities that interact with immune response antigens, adhesion molecules, cell-trafficking molecules, and a variety of other antigens involved in heterogeneous pathways. Thymoglobulin acts as a rapid T-cell depleting agent, primarily through complement-dependent cell lysis in the blood compartment and apoptotic cell death in lymphoid tissues. Although the primary immunosuppressive effect is T-cell depletion, Thymoglobulin has also been shown to modulate cell surface markers, including a number of integrins and intercellular adhesion molecules that facilitate leukocyte adhesion to the endothelium. Treatment with Thymoglobulin has been shown to be associated with both short- and long-term changes in T-cell populations, generating altered homeostasis characterized by expansion of specific T-cell subsets that have been shown to exhibit regulatory suppressor functions. Further exploration of the mechanisms of action of Thymoglobulin will be important to guiding therapy with this widely used agent in the transplant setting, as well as in emerging therapeutic areas.
引用
收藏
页码:S5 / S10
页数:6
相关论文
共 71 条
[1]   Short course induction immunosuppression with thymoglobulin for renal transplant recipients [J].
Agha, IA ;
Rueda, J ;
Alvarez, A ;
Singer, GG ;
Miller, BW ;
Flavin, K ;
Lowell, JA ;
Shenoy, S ;
Howard, TK ;
Ramachandran, V ;
Irish, W ;
Schnitzle, MA ;
Brennan, DC .
TRANSPLANTATION, 2002, 73 (03) :473-475
[2]   CD32-mediated platelet aggregation in vitro by anti-thymocyte globulin:: Implication of therapy-induced in vivo thrombocytopenia [J].
Ankersmit, HJ ;
Roth, GA ;
Moser, B ;
Zuckermann, A ;
Brunner, M ;
Rosin, C ;
Buchta, C ;
Bielek, E ;
Schmid, W ;
Jensen-Jarolim, E ;
Wolner, E ;
Boltz-Nitulescu, G ;
Volf, I .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (06) :754-759
[3]   Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO) [J].
Bacigalupo, A ;
Lamparelli, T ;
Bruzzi, P ;
Guidi, S ;
Alessandrino, PE ;
di Bartolomeo, P ;
Oneto, R ;
Bruno, B ;
Barbanti, M ;
Sacchi, N ;
Van Lint, MT ;
Bosi, A .
BLOOD, 2001, 98 (10) :2942-2947
[4]   TNFα and CD95-L contribute to apoptosis of activated lymphocytes triggered by ATGs [J].
Bonnefoy-Berard, N ;
Genestier, L ;
Preville, X ;
Revillard, JP .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :775-777
[5]  
BonnefoyBerard N, 1996, J HEART LUNG TRANSPL, V15, P435
[6]   ANTIBODIES AGAINST FUNCTIONAL LEUKOCYTE SURFACE MOLECULES IN POLYCLONAL ANTILYMPHOCYTE AND ANTITHYMOCYTE GLOBULINS [J].
BONNEFOYBERARD, N ;
VINCENT, C ;
REVILLARD, JP .
TRANSPLANTATION, 1991, 51 (03) :669-673
[7]  
BONNEFOYBERARD N, 1994, BLOOD, V83, P1051
[8]  
BONNEFOYBERARD N, 1992, BLOOD, V79, P2164
[9]   COMPARATIVE POLYCLONAL ANTITHYMOCYTE GLOBULIN AND ANTILYMPHOCYTE ANTILYMPHOBLAST GLOBULIN ANTI-CD ANTIGEN-ANALYSIS BY FLOW-CYTOMETRY [J].
BOURDAGE, JS ;
HAMLIN, DM .
TRANSPLANTATION, 1995, 59 (08) :1194-1200
[10]   A randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients [J].
Brennan, DC ;
Flavin, K ;
Lowell, JA ;
Howard, TK ;
Shenoy, S ;
Burgess, S ;
Dolan, S ;
Kano, JM ;
Mahon, M ;
Schnitzler, MA ;
Woodward, R ;
Irish, W ;
Singer, GG .
TRANSPLANTATION, 1999, 67 (07) :1011-1018